An analytical framework for immunization programs in Canada

被引:96
作者
Erickson, LJ [1 ]
De Wals, P
Farand, L
机构
[1] Univ Montreal, Dept Adm Sante, Montreal, PQ, Canada
[2] Agence Evaluat Technol & Modes Intervent Sante Qu, AETMIS, Montreal, PQ H3A 2S9, Canada
[3] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada
关键词
vaccine; public health; immunization;
D O I
10.1016/j.vaccine.2004.10.029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent years have seen an increase in the number of new vaccines available on the Canadian market, and increasing divergence in provincial and territorial immunization programs as jurisdictions must choose among available health interventions with limited funding. We present an analytical framework, which we have developed to assist in the analysis and comparison of potential immunization programs. The framework includes 58 criteria classified into 13 categories, including the burden of disease, vaccine characteristics and immunization strategy, cost-effectiveness, acceptability, feasibility, and evaluability of program, research questions, equity, ethical, legal and political considerations. To date this framework has been utilized in a variety of different contexts, such as to structure expert presentations and reports and to examine the degree of consensus and divergence among experts, and to establish priorities. It can be transformed for a variety of other uses such as educating health professionals and the general public about immunization. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2470 / 2476
页数:7
相关论文
共 41 条
[1]  
[Anonymous], 1997, CAN COMMUN DIS REP, V23, P1
[2]  
Brisson M., 2003, Journal of Medical Virology, V70, pS31, DOI 10.1002/jmv.10317
[3]   The cost-effectiveness of varicella vaccination in Canada [J].
Brisson, M ;
Edmunds, WJ .
VACCINE, 2002, 20 (7-8) :1113-1125
[4]  
Canadian Task Force on the Periodic Health Examination, 1994, CAN GUID CLIN PREV H
[5]  
*COM IMM QUEB, 2000, RAPP UT VACC CONTR V
[6]  
*COM IMM QUEB, 2002, PERT INTR VACC MEN C
[7]  
*CTR INF DIS PREV, 2002, CAN IMM GUID
[8]   Morbidity of pertussis in adolescents and adults [J].
De Serres, G ;
Shadmani, R ;
Duval, B ;
Boulianne, N ;
Déry, P ;
Fradet, MD ;
Rochette, L ;
Halperin, SA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :174-179
[9]   Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease [J].
De Wals, P ;
Nguyen, VH ;
Erickson, LJ ;
Guay, M ;
Drapeau, J ;
St-Laurent, J .
VACCINE, 2004, 22 (9-10) :1233-1240
[10]  
De Wals P, 2002, Can Commun Dis Rep, V28, P61